Secţia Oncologie Medicală

Secția de Oncologie Medicală a Spitalului Județean de Urgență ”Dr. Constantin Opriș” Baia Mare funcționează cu 50 de paturi, din care Compartimentul de Radioterapie cu 3 paturi.
Sunt 4 medici primari în secția cu paturi, 1 medic primar în cabinetul din Ambulatoriu.
Secția de Oncologie Medicală gestionează performant toată patologia oncologică, terapie, evidențe, raportări gestionate PC prin soft-uri dedicate, altele decât cele utilitare ale spitalului cu care sunt compatibile, dar gestionează competent și programul de oncologie, existând și un Cabinet de Oncologie Medicală.

VEZI  Studii clinice derulate în cadrul Secției Oncologie

 

În derulare studii clinice:

1. Clinical Study Protocol
Efficacy and Safety of Long-Term (6 Months) Innohep ® Treatment Versus Anticoagulation with a Vitamin K Antagonist (Warfarin) for the Treatment of Acute Venous Thromboembolism in Cancer Patiens /IN 0901 INT
2. FORTIS –M: A Phase 3, randomized, double –blind, placebo-controlled study of oral talactoferrin in addition to best supportive care in patients with non-small cell lung cancer who have failed two or more prior treatment regimens
3. A Double –blind, Randomised, Parallel Group, Phase III Study to Demonstrate Equivalent Efficacy and Comparable Safety of CT-P6 and Herceptin, Both in Combination with Paclitaxel, in Patiens with Metastatic Breast Cancer
4. EXPAND (Erbitux in combination with Xeloda and Cisplatin in advanced esophago-gastric cancer) Open –label, randomized, controlled, multicenter phase III study investigating cetuximab in combination with capecitabine (Xeloda, X) and cisplatin (P) versus XP alone as first –line treatment for subjects with advanced gastric adenocarcinoma including adenocarcinoma of the gastroesophageal junction.
5. CLINICAL STUDY PROTOCOL M10-300
An Open –Label, Randomized Phase 2 Study of ABT - 869 in Combination with mFolfox 6 (Oxaliplatin, 5-Fluorouracil, and Folinic Acid) Versus Bevacizumab in Combination with mFolfox 6 as Second – line Treatment of Subject with Advanced Colorectal Cancer.
6. CLINICAL STUDY PROTOCOL M10-300
An Open – Label, Randomized Phase 2 Study of ABT - 869 in Combination with mFolfox 6 (Oxaliplatin, 5 Fluorouracil, and Folinic Acid) Versus Bevacizumab in Combination with mFolfox 6 as Second –line Treatment of Subjects with Advanced Colorectal Cancer
7. CLINICAL STUDY PROTOCOL M10-963
An Open –label, Randomized Phase 3 Study of the Efficacy and Tolerability of Linifanib (ABT -869) versus Sorafenib in Subjects with Advanced Hepatocellular Carcinoma (HCC)
8. CLINICAL STUDY PROTOCOL M10-300
An Open –Label, Randomized Phase 2 Study of ABT -869 in Combination with m Folfox 6 (Oxaliplatin, 5-Fluorouracil, and Folinic Acid) Versus Bevacizumab in Combination with mFolfox 6 as Second-line Treatment of Subjects with Advanced Colorectal Cancer
9. Efficacy and safety of XM22
In patiens with non small cell lung cancer receiving Cisplatin /Etoposid chemotherapy. A multinational, multicentre, randomised, double – blind placebo-controlled study

Compartimentul de Radioterapie:

- 18 paturi;
- 4 medici primari;
- va prelua pacienții veniți din toată zona (inclusiv din județele limitrofe), pentru cobaltoterapie;
- sistem de cobaltoterapie Theraton cu planning computerizat, interfața Dicom, montate, în curs de autorizare.

Medicii Secției de Oncologie Medicală:

1. Dr. Pușcă Eva – Medic Șef Secție Oncologie, Competențe Chimioterapie
2. Dr. Filip Dumitru –Medic Primar Oncologie, Competențe Chimioterapie
3. Dr. Herzal Alina - Medic Primar Oncologie, Competențe Chimioterapie
4. Dr. Kazai Tiberiu - Medic Primar Oncologie, Radioterapie

Asistent șef: Ionce Ramona

Localizare pe hartă

Top